Myelodysplastic Syndrome
Syros slashes workforce and appoints new CEO amid partnership losses
Anika Sharma
Syros Pharmaceuticals is undergoing a significant transformation, which includes a workforce reduction of 35%, as it narrows its focus to ...
AbbVie Withdraws from CD47 Arena, Ending Partnership with I-Mab
Anika Sharma
AbbVie has officially distanced itself from I-Mab, withdrawing from a once-promising collaboration focused on the anti-CD47 antibody lemzoparlimab, leaving I-Mab ...
Briqulimab Phase I Study Doses First Patient With Lower-Risk MDS
SG Tylor
Source – Jasper Therapeutics Jasper Therapeutics has initiated a Phase I trial (NCT05903274) to evaluate the use of briquilimab as ...
